Inhibitors of Notch signaling (e.g. γ-secretase inhibitor) could partially suppress the function of reprogramming factors (Sox-2, Oct-4, Nanog, etc) involved in the formation of iBCSCs [8], and enhanced the radiation sensitivity of breast cancer cells [95]. The gene discussed is NANOG; the disease is breast carcinoma.